Indication
Treatment of 5q spinal muscular atrophy (Pre-symptomatic infants).
Medicine details
- Medicine name:
- nusinersen (Spinraza)
- SMC ID:
- SMC2877
- Pharmaceutical company
- Biogen
- BNF chapter
- Musculoskeletal and joint diseases
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- 01 June 2026